Alergia e Imunologia

Más notícias para a Paxlovid? Coronavírus pode encontrar múltiplas vias para escapar do medicamento para COVID-19.

5 Jul, 2022 | 12:01h

Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug – Science

Ver também: SARS-CoV-2 can evade Paxlovid by multiple mechanisms – News Medical

---

Opinião | FDA: não faça nenhum movimento para mudar a composição da vacina contra Covid-19.

5 Jul, 2022 | 11:59h

FDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT

---

Anticorpos para combater infecções virais: estratégias de desenvolvimento e progresso.

5 Jul, 2022 | 11:58h

Antibodies to combat viral infections: development strategies and progress – Nature Reviews Drug Discovery (se o acesso a este link for pago, tente este no PMC)

---

Consenso para definição, classificação, diagnóstico e tratamento da urticária.

4 Jul, 2022 | 12:10h

Taiwanese dermatological association consensus for the definition, classification, diagnosis, and management of urticaria: A 2021 update – Journal of the Formosan Medical Association

---

M-A | Reprodutibilidade do desafio alimentar ao leite de vaca.

19 Jun, 2022 | 15:15h

Reproducibility of food challenge to cow’s milk: a systematic review with individual participant data meta-analysis – Journal of Allergy and Clinical Immunology

---

Posicionamento científico | Direção diagnóstica do cuidado terapêutico para alergias e intolerâncias alimentares pediátricas.

19 Jun, 2022 | 14:17h

Diagnostic therapeutic care pathway for pediatric food allergies and intolerances in Italy: a joint position paper by the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP) and the Italian Society for Pediatric Allergy and Immunology (SIAIP) – Italian Journal of Pediatrics

---

Imunoterapia direcionada ao hospedeiro para infecções virais e bacterianas: passado, presente e futuro.

19 Jun, 2022 | 13:07h

Host-directed immunotherapy of viral and bacterial infections: past, present and future – Nature Reviews Immunology (se o acesso a este link for pago, tente este no PMC)

 

Comentário no Twitter

A Perspective in @NatRevImmunol reflects on the historical development of host-directed immunotherapeutic interventions for infections and how historical insights can be used in the therapy of SARS-CoV-2 and Mycobacterium tuberculosis infections. https://t.co/5WOXzePpFS pic.twitter.com/dpj1XNi2me

— Nature Portfolio (@NaturePortfolio) June 11, 2022

 

---

Outro estudo sugere que a variante Ômicron está associada com risco reduzido de síndrome inflamatória multissistêmica em crianças em comparação a variantes anteriores do SARS-CoV-2.

16 Jun, 2022 | 14:01h

Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave – JAMA Pediatrics

Estudo relacionado: Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel – JAMA E Commentary: Kids’ COVID syndrome—MIS-C—less severe in Omicron – CIDRAP

 

Comentário no Twitter

Study found that the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection during the #Omicron wave substantially lower compared to previous #SARSCoV2 variants. https://t.co/GYrz9XA72Z

— JAMA Pediatrics (@JAMAPediatrics) June 8, 2022

 

---

Dados originais e revisão sistemática | Reações de hipersensibilidade relacionada a medicamentos levando ao departamento de emergência.

16 Jun, 2022 | 13:27h

Drug-Related Hypersensitivity Reactions Leading to Emergency Department: Original Data and Systematic Review – Journal of Clinical Medicine

---

M-A | Inibidores orais da Janus-quinase no tratamento da dermatite atópica.

13 Jun, 2022 | 13:42h

Oral Janus kinase inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis – Skin Health and Disease

Comentário: Systematic Review Suggests Oral JAK Inhibitors Effective in AD – HCP Live

---